Full-Time
Accounting Manager
Automated cell therapy manufacturing and development platform
Mid, Senior
San Bruno, CA, USA
- BS in Accounting with a CPA or MBA desired
- Minimum 6 years professional experience with at least 2 years in accounting management (i.e., assistant controller, accounting manager)
- 5+ years manufacturing experience preferred
- Self-awareness, integrity, authenticity, and a growth/entrepreneurial mindset
- Perform monthly close, account reconciliations, and account analytics
- Lead cost accounting for instrument sales and service revenue lines, including development of accounting processes and procedures to support accounting close
- Prepare monthly variance reports and analyze the reasons behind monthly product/department performance and results
- Provide fluctuation analysis for product margins and costs by profit and cost centers as well as variances to budget/forecast
- Oversee accounts payable function and operations
- Coordinate and prepare timely internal and external monthly financial statements
- Train, coach, and retain skilled accounting staff
- Provide management with information vital to the decision-making process
- Key contributor in implementation and user-acceptance training of SAP Audit support and preparation of audit requests/support
- Assist with ad-hoc projects
- Perform other similar and related duties as required
Cellares, as the pioneering Integrated Development and Manufacturing Organization (IDMO), is reshaping the cell therapy manufacturing industry with its unique Industry 4.0 approach, integrating all necessary technologies into a single, high-throughput platform called the Cell Shuttle. This end-to-end automation system not only accelerates drug development and manufacturing but also significantly reduces process failure rates and manufacturing costs. With its strategically located Smart Factories and a robust financial backing of over $355 million, Cellares is well-positioned to meet global patient demand for cell therapies, offering potential partners a competitive edge in the rapidly evolving cell therapy market.
Company Stage
Series C
Total Funding
$373M
Headquarters
South San Francisco, California
Founded
2019